Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. - Jeon YH; Lee N; Yoo J; Won S; Shin SK; Kim KH; Park JG; Kim MG; Kim HR; Oh K; Lee DS (Biomedicines, 2022)